Kiromic BioPharma Inc (KRBP)
3.20
-0.02
(-0.62%)
USD |
OTCM |
May 31, 16:00
Kiromic BioPharma Net Income (Quarterly): -6.148M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -6.148M |
| December 31, 2023 | -4.691M |
| September 30, 2023 | -4.194M |
| June 30, 2023 | -6.764M |
| March 31, 2023 | -5.30M |
| December 31, 2022 | -7.068M |
| September 30, 2022 | -11.86M |
| June 30, 2022 | -8.435M |
| March 31, 2022 | -7.368M |
| December 31, 2021 | -10.64M |
| September 30, 2021 | -6.125M |
| Date | Value |
|---|---|
| June 30, 2021 | -4.974M |
| March 31, 2021 | -3.854M |
| December 31, 2020 | -3.565M |
| September 30, 2020 | -2.416M |
| June 30, 2020 | -11.37M |
| March 31, 2020 | -1.853M |
| December 31, 2019 | -2.170M |
| September 30, 2019 | -0.8869M |
| June 30, 2019 | -0.2804M |
| March 31, 2019 | -0.3909M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-11.86M
Minimum
Sep 2022
-0.2804M
Maximum
Jun 2019
-5.498M
Average
-5.137M
Median
Net Income (Quarterly) Benchmarks
| Lisata Therapeutics Inc | -5.401M |
| Achieve Life Sciences Inc | -6.494M |
| Syra Health Corp | -1.447M |
| CEL-SCI Corp | -7.245M |
| AIM ImmunoTech Inc | -5.817M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 5.113M |
| EPS Diluted (Quarterly) | -1.00 |
| Enterprise Value | 13.45M |
| Earnings Yield | -309.4% |